|
|
|||||||||
In Brief |
| The first 20% of the full text of this article appears below. |
Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): The New Horizon For Children Who Have DPKD. Rizk D, Chapman A. Pediatr Nephrol. 2008;23 :1029 –1036[CrossRef][Medline]
Autosomal Recessive Polycystic Kidney Disease. Zerres K. Clin Investig. 1992;70 :794 –801[Medline]
Familial Juvenile Nephronophthisis. Konrad M, Saunier S, Calado J, et al. J Mol Med. 1998;76 :310 –316[CrossRef][Medline]
Congenital Nephropathies and Uropathies. Becker N, Avner E. Pediatr Clin North Am. 1995;42 :1324 –1328
Polycystic kidney disease is the most common hereditary renal malformation. Many malformation syndromes are associated with renal cysts, the primary renal diseases being autosomal dominant polycystic kidney disease (ADPKD), autosomal recessive polycystic kidney disease (ARPKD), and juvenile nephronophthisis (NPH).
ADPKD is the most common inherited renal disease, affecting 1 in 800 live births in the United States. The genetic defect is present in utero, but most affected children are asymptomatic. The usual onset of clinical manifestations occurs from the third through
Jacques Benun, MD
Carol Lewis, MD
Hasbro Children's Hospital
Providence, RI
Janet R. Serwint, MD, Consulting Editor
![]()
CiteULike
Connotea
Del.icio.us
Digg
Facebook
Reddit
Technorati
Twitter What's this?
| HOME | HELP | CONTACT US | SUBSCRIPTIONS | CME | ARCHIVE | SEARCH | TABLE OF CONTENTS |